Get startedLog in
    Picture of Xeris Biopharma Holdings logo

    XERS — Xeris Biopharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Xeris Expects To Exceed Full-Year 2024 Financial Guidance

    Picture of Xeris Biopharma Holdings logoXeris Biopharma Holdings
    10/01/2025 12:28
    Jan 10 (Reuters) - Xeris Biopharma Holdings Inc
 XERS.O :
    * XERIS EXPECTS TO EXCEED FULL-YEAR 2024 FINANCIAL GUIDANCE
    * : FULL-YEAR 2024 TOTAL REVENUE PROJECTED TO BE $203
MILLION
    * FY2024 REVENUE VIEW $199.7 MILLION -- LSEG IBES DATA

Source text:  ID:nBw8Qt0pka 
Further company coverage:  XERS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Xeris Biopharma Holdings

    See all news